 Cell Proliferation
"Cell Proliferation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
| Descriptor ID |
D049109
|
| MeSH Number(s) |
G04.161.750 G07.345.249.410.750
|
| Concept/Terms |
Cell Proliferation- Cell Proliferation
- Proliferation, Cell
- Cellular Proliferation
- Proliferation, Cellular
- Cell Multiplication
- Multiplication, Cell
- Cell Growth in Number
- Cell Number Growth
- Growth, Cell Number
- Number Growth, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Proliferation".
Below are MeSH descriptors whose meaning is more specific than "Cell Proliferation".
This graph shows the total number of publications written about "Cell Proliferation" by people in this website by year, and whether "Cell Proliferation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 2 | 24 | 26 | | 2005 | 9 | 58 | 67 | | 2006 | 9 | 52 | 61 | | 2007 | 7 | 49 | 56 | | 2008 | 9 | 56 | 65 | | 2009 | 9 | 71 | 80 | | 2010 | 10 | 79 | 89 | | 2011 | 13 | 70 | 83 | | 2012 | 13 | 81 | 94 | | 2013 | 14 | 94 | 108 | | 2014 | 14 | 75 | 89 | | 2015 | 14 | 67 | 81 | | 2016 | 10 | 77 | 87 | | 2017 | 14 | 80 | 94 | | 2018 | 16 | 68 | 84 | | 2019 | 11 | 61 | 72 | | 2020 | 5 | 61 | 66 | | 2021 | 3 | 54 | 57 | | 2022 | 0 | 12 | 12 | | 2023 | 0 | 11 | 11 | | 2024 | 9 | 21 | 30 | | 2025 | 2 | 13 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Proliferation" by people in Profiles.
-
Campa?a MB, Perkins MR, McCabe MC, Neumann A, Larson ED, Fantauzzo KA. PDGFRa/? heterodimer activation negatively affects downstream ERK1/2 signaling and cellular proliferation. Nat Commun. 2025 May 22; 16(1):4754.
-
Panja S, Kapoor E, Siddhanta K, Jogdeo CM, Sil D, Khan RI, Kumari N, Ding L, Gendelman HE, Singh AB, Oupick? D. Bioactive polymers as stimulus-responsive anti-metastatic combination agents to treat pancreatic cancer. Biomaterials. 2025 Sep; 320:123255.
-
Pham-Danis C, Novak AJ, Danis E, McClellan SM, Leach L, Yarnell MC, Ebmeier CC, Tasian SK, Kohler ME. Restoration of LAT activity improves CAR T?cell sensitivity and persistence in response to antigen-low acute lymphoblastic leukemia. Cancer Cell. 2025 Mar 10; 43(3):482-502.e9.
-
Ward AV, Riley D, Cosper KE, Finlay-Schultz J, Brechbuhl HM, Libby AE, Hill KB, Varshney RR, Kabos P, Rudolph MC, Sartorius CA. Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025 Mar 07; 27(1):32.
-
Jones T, Feng J, Luyties O, Cozzolino K, Sanford L, Rimel JK, Ebmeier CC, Shelby GS, Watts LP, Rodino J, Rajagopal N, Hu S, Brennan F, Maas ZL, Alnemy S, Richter WF, Koh AF, Cronin NB, Madduri A, Das J, Cooper E, Hamman KB, Carulli JP, Allen MA, Spencer S, Kotecha A, Marineau JJ, Greber BJ, Dowell RD, Taatjes DJ. TFIIH kinase CDK7 drives cell proliferation through a common core transcription factor network. Sci Adv. 2025 Feb 28; 11(9):eadr9660.
-
Wu G, Taylor E, Youmans DT, Arnoult N, Cech TR. Rapid dynamics allow the low-abundance RTEL1 helicase to promote telomere replication. Nucleic Acids Res. 2025 Feb 27; 53(5).
-
Sama GR, Arguien MN, Hoffman TE, Fairbanks BD, Trujilo-Lemon M, Keyser S, Anseth KS, Spencer SL, Bowman CN. Design and Synthesis of Hydrolytically Degradable PEG Carbamate, Carbonate, and Ester Derivatives to Induce Reversible Biostasis. Biomacromolecules. 2025 Mar 10; 26(3):1850-1859.
-
Voss DM, Kral AJ, Sim G, Utama R, Lin KT, Cizmeciyan C, Schafer B, Cunniff PJ, Vakoc CR, Caruthers MH, Mishra L, Krainer AR. PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1/2 in hepatocellular carcinoma. J Biol Chem. 2025 Apr; 301(4):108345.
-
Esquer H, Zhou Q, LaBarbera DV. Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer. Cells. 2025 02 20; 14(5).
-
Matsuzaki H, Kai K, Komohara Y, Yano H, Pan C, Fujiwara Y, Yamada R, Iwauchi A, Fukasawa N, Tanaka T, Shimoda M, Watanabe H, Maruyama T, Takeo T, Mikami Y, Mukasa A. Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages. Cancer Sci. 2025 Apr; 116(4):897-909.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|